New Penn Medicine center brings immunotherapy research to brain tumor treatment
The team at the new Translational Center of Excellence in the Abramson Cancer Center will investigate new immune therapies for glioblastoma, the most common and lethal form of brain cancer, and design new CAR T cell therapies.
FULL STORY AT Penn Medicine News →